🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of uncertain source.

Several experts said the popularity for the experimental drug could be linked to the rising cost of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Content Removal

According to TikTok, the platform has removed problematic content and banned associated keywords and query recommendations. The company stated it was committed to keeping the service secure and investing in strengthening compliance measures.

Online Trading Operations

Research also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of members, filled with photos of slimming results, glowing testimonials and detailed guides for preparing or administering at home.

After moments of entering one community, a seller posted WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or past usage.

Item Information and Pricing

Inside these groups, messages show dark colored parcels with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20mg. When questioned how much time a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service said it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Even if the research behind this drug is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has previously seen patients harmed by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental substance not yet approved … may subject users to potentially serious health risks”.